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See related research by Petitpas et al., http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1277-6
We read the review by Petitpal et al on intra-osseous ac-
cess (IOA) in adults with great interest [1]. The review
was concise, and offers a comprehensive overview of
IOA. However, we disagree with one key aspect.
The authors state that: “Despite a lack of evidence-
based medicine, administration of lidocaine … has been
proposed in conscious patients”. Two studies are cited
to support that IOA is painful, and that it is unclear if
lidocaine decreases pain associated with IOA. The first
study is a case series (n = 26) which does not state if
lidocaine was given and at what dose [2]. In the second
study, 22 conscious patients received an intra-osseous
(IO) needle. Of the 12 that received local anaesthesia,
four were pain-free whereas the remainder experienced
some pain. However, as the study did not report pain
scores it is unclear but possible that the group with lido-
caine experienced less pain [3].
A short-cut review from 2013 assessed the evidence for
the use of local anaesthetics in IOA [4]. The review identi-
fied one conference abstract and one open-label study.
Both were small (n = 10), open-label and manufacturer-
sponsored, and compared different doses of lidocaine and
insertion sites with regards to pain. Based on those find-
ings the review concluded that injecting lidocaine both be-
fore and after flushing an IO needle is an effective method
of reducing the pain of fluid infusion.
In clinical practice, using lidocaine for IO insertion in
conscious patients takes little time and is unlikely to cause
harm. We agree with the authors that there is a paucity of
evidence, but the little research that does exist supports
administering lidocaine in order to prevent pain.
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